US Broker Ratings

Revolution Medicines, Inc. (RVMD) Stock Analysis: 38.65% Potential Upside Ignites Investor Interest

Revolution Medicines, Inc. (RVMD) is capturing the attention of investors with its substantial potential upside of 38.65%, as highlighted by its average target price of $133.70 against the current market..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Unpacking a 28.67% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has been making waves in the biotech industry, particularly for investors with an eye on the burgeoning field of metabolic dysfunction-associated steatohepatitis (MASH). Headquartered in..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 56% Potential Upside in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT) is capturing the attention of investors with its promising potential in the biotechnology sector. Based in Miami, Florida, Summit Therapeutics is dedicated to the discovery,..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a 31.71% Potential Upside in the Healthcare Sector

Revvity, Inc. (NYSE: RVTY), a key player in the healthcare sector, presents a compelling investment opportunity with a notable 31.71% potential upside based on current analyst ratings. As a significant..

Elanco Animal Health (ELAN) Stock Analysis: 24% Upside Potential and Robust Revenue Growth

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector specializing in specialty and generic drug manufacturing, presents a compelling opportunity for investors, underscored by its strong..

Baxter International Inc. (BAX) Stock Analysis: Evaluating a 28.95% Potential Upside Amid Market Challenges

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, stands at a crucial juncture for individual investors. With a robust market cap of $8.85 billion, the company..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring an 18.44% Upside Potential

Henry Schein, Inc. (NASDAQ: HSIC), a leading player in the healthcare sector specializing in medical distribution, has recently caught the attention of investors with its promising 18.44% potential upside. With..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring a 25.76% Potential Upside in CNS Therapies

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is making waves in the biotechnology sector with its innovative focus on central nervous system (CNS) disorders. This New York-based biopharmaceutical company is capturing investor..

Doximity, Inc. (DOCS) Stock Analysis: Exploring an 85% Upside Potential in Health Information Services

Doximity, Inc. (NYSE: DOCS) is carving a niche in the healthcare sector with its digital platform tailored for medical professionals. With a market capitalization of $3.96 billion, Doximity is a..

Encompass Health Corporation (EHC) Stock Analysis: Strong Buy Ratings Signal a 33% Upside Potential

Encompass Health Corporation (NYSE: EHC) stands out in the healthcare sector as a robust player within the medical care facilities industry. With a market capitalization of $10.79 billion, this Birmingham,..

Bruker Corporation (BRKR) Investor Outlook: Assessing a 27.31% Upside Potential

Bruker Corporation (NASDAQ: BRKR), a key player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors looking to navigate the complexities of the scientific instruments..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: A 13.42% Potential Upside Beckons Investors

For investors focused on opportunities in the healthcare sector, Takeda Pharmaceutical Company Limited (NYSE: TAK) presents a compelling case with its positioning in the specialty and generic drug manufacturing industry...

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Powerhouse with 25% Upside Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO) has emerged as a compelling contender in the biotechnology sector, capturing investor attention with its innovative enzyme-based delivery technologies and diverse therapeutic portfolio. With a..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 28% Potential Upside in the Animal Health Giant

Zoetis Inc. (NYSE: ZTS), a leader in the animal health industry, is capturing the attention of investors with its robust portfolio and a promising potential upside of 28.12%. As the..

West Pharmaceutical Services (WST): Analyst Consensus Suggests a 23% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a titan in the healthcare sector specializing in medical instruments and supplies, is capturing investor attention with its notable growth prospects. As of the..

Merck & Company, Inc. (MRK) Stock Analysis: Robust Growth and Strategic Partnerships Drive Positive Investor Sentiment

Merck & Company, Inc. (NYSE: MRK), a titan in the healthcare sector, continues to attract investor attention with its expansive portfolio and strategic collaborations. Currently trading at $121.42, Merck’s stock..

Roivant Sciences Ltd. (ROIV)

⚠️ No article content returned.

..

Chemed Corp (CHE) Stock Analysis: Exploring a 14.81% Upside Potential

Chemed Corp (CHE), an influential player in the healthcare sector, stands at an intriguing junction for investors seeking steady returns and potential growth. With a current market capitalization of $5.31..

Insmed Incorporated (INSM) Stock Analysis: Exploring a 37% Potential Upside with Robust Pipeline

Insmed Incorporated (NASDAQ: INSM) stands as a notable player in the biotechnology sector, offering a compelling investment opportunity characterized by a strong pipeline of therapies for serious and rare diseases...

Qiagen N.V. (QGEN) Stock Report: Exploring a 35.64% Potential Upside in the Diagnostics Sector

As individual investors navigate the complexities of the healthcare sector, Qiagen N.V. (NASDAQ: QGEN) emerges as a noteworthy player in the Diagnostics & Research industry. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds